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Disease networks are increasingly explored as a complement to networks centered around interactions between genes and proteins. The
quality of disease networks is heavily dependent on the amount and quality of phenotype information in phenotype databases of
human genetic diseases. We explored which aspects of phenotype database architecture and content best reﬂect the underlying biology
of disease.We used the OMIM-based HPO, Orphanet, and POSSUMphenotype databases for this purpose and devised a biological coher-
ence score based on the sharing of gene ontology annotation to investigate the degree to which phenotype similarity in these databases
reﬂects related pathobiology. Our analyses support the notion that a ﬁne-grained phenotype ontology enhances the accuracy of
phenome representation. In addition, we ﬁnd that the OMIM database that is most used by the human genetics community is heavily
underannotated.We show that this problem can easily be overcome by simply adding data available in the POSSUMdatabase to improve
OMIM phenotype representations in the HPO. Also, we ﬁnd that the use of feature frequency estimates—currently implemented only in
the Orphanet database—signiﬁcantly improves the quality of the phenome representation. Our data suggest that there is much to be
gained by improving human phenome databases and that some of the measures needed to achieve this are relatively easy to implement.
More generally, we propose that curation andmore systematic annotation of human phenome databases can greatly improve the power
of the phenotype for genetic disease analysis.Introduction
The human genome is deﬁned by the complete DNA
sequence and by the functional relationships between all
human genes. Similarly, the human phenome can be
viewed as the sum of all human phenotypes and the rela-
tionships that exist between the various diseases and traits.
By correlating networks of genes and phenotypes,1,2 we
can investigate disease pathobiology at the whole-phe-
nome scale.1–13 Such analyses build on the premise that
phenotypic overlap is a good predictor of genetic relation-
ships, and their success relies on the quality and amount of
the phenotype data.5,8,11–13
The importance of using adequate phenotype informa-
tion is obvious both for clinical diagnosis and for proper
disease classiﬁcation for research studies. The concept of
disease families that can be organized into phenotype
networks has spurred new interest into more precise and
more comprehensive phenotype annotation.14–17 For
example, mutations in proteins involved in ciliary func-
tioning result in overlapping phenotypes, collectively
referred to as ciliopathies.18 The realization that features
such as retinopathy and kidney cysts are indicative of
disturbed cilium function has enabled the identiﬁcation
of ciliary diseases based only on their phenotype,16,19,20
as well as the identiﬁcation of novel ciliopathy genes.21
This and other examples suggest that much can be learned
from disease comparisons on a phenome-wide scale. Such
phenotype comparisons will need to become more sophis-
ticated as correlations are sought between genetic variants
and phenotypic features in ever greater detail, up to the
level of individual genotype-phenotype mappings across
the genome and across populations.22The AmericanHere we analyzed three human phenotype data sets to
investigate which characteristics of the disease phenotype
descriptions in the available databases would maximize
their utility. We examined OMIM (Online Mendelian
Inheritance in Man)23 phenotype descriptions that had
been converted into structured form by using a recently
developed phenotype ontology called the HPO24 (Human
Phenotype Ontology). In addition we performed analyses
on the diagnosis-oriented Orphanet25 and POSSUM
(Pictures Of Standard Syndromes and Undiagnosed Mal-
formations)26 databases. By using the sharing of Gene
Ontology annotation as a measure of biological coherence
between diseases, we investigated the degree to which
phenotype similarity in these databases reﬂects shared
pathobiology for different treatments of the phenotype
data. It is important to note that differences in information
content and structure of the HPO, POSSUM, and Orphanet
databases preclude comparing them directly with each
other, so comparisons were always between different treat-
ments of data from a single database. To remove biases
that remain even when comparing treatments within
one database, all results were expressed relative to random
permutations of the phenotypes in that database.
We ﬁnd that a ﬁne-grained phenotype ontology
improves phenome representation, as does inclusion of
feature frequency estimates. In addition, we ﬁnd that the
OMIM database that is most used by the community is
heavily underannotated, at least for the purpose of system-
atic phenotype comparisons. We show that this problem
can easily be overcome by simply adding data available
in the POSSUM database to improve phenotype represen-
tations in the structured HPO implementation of OMIM.
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improving human phenome databases and that some of
the measures needed to achieve this are relatively easy to
implement. Although manual curation and systematic
annotation of disease phenotypes may require substantial
investment, we feel that this is justiﬁed and necessary to
realize the full potential of systematic genotype-pheno-
type correlations and phenomics.
Material and Methods
Data Sets
In order to compare databases for the relationships between their
phenotype content and the underlying genetic architecture, we
ﬁrst needed to formalize phenotype descriptions. Several current
disease phenotype databases already deﬁne their own standard-
ized feature terms. The diagnosis-oriented LDDB (London Dys-
morphology Database),27 Orphanet,25 and POSSUM26 databases
all use a controlled vocabulary to systematically annotate disease
phenotypes with features, an approach that facilitates differential
diagnosis. We used Orphanet and POSSUM in our analyses as
examples of such structured human phenome databases.
However, the largest phenotype database available, the OMIM,23
is intended to serve more as an information repository than as a
diagnostic tool. As such, it does not use a controlled vocabulary.
To enable phenotype comparisons to be conducted for this data-
base, previous efforts have employed text mining to convert the
free text records into feature lists, with terms deﬁned in external
vocabularies.8,11 In this study, we used another recent conversion
of OMIM phenotype data, which uses a manually curated system-
atic hierarchical vocabulary (or ontology) to describe OMIM
phenotypes.24 This ontology, known as the Human Phenotype
Ontology (HPO),wasusedby its creators to annotateOMIMpheno-
types with feature lists based on annotation taken from the OMIM
database itself, converting it into a structured phenotype database.
The HPO is comprehensive, with more than 8000 terms organized
into a deep hierarchical structure (Table 1). We used HPO version
1.4, downloaded on December 18, 2008, restricting ourselves to
the 4345 syndromes that also had OMIM text descriptions
(excluded records listed in Table S3 available online).
The POSSUM andOrphanet phenotype data were received upon
request from the Murdoch Children’s Research Institute in Mel-
bourne, Australia, and the INSERM in Paris, France, respectively.
The POSSUMdata (database version 5.7.3) were received in August
2007 whereas the Orphanet data were received in July 2008 (the
Orphanet database undergoes continuous development and does
not make versioned releases).
All disease to gene mappings were based on the mapping of
OMIM IDs to HUGO gene symbols in OMIM’s MorbidMap and
GeneMap ﬁles. The POSSUM and Orphanet diseases were mapped
to genes through their associated OMIM IDs.
Cluster Biological Coherence Score Calculation
Procedure
We used a cluster-based approach because we are interested in the
degree to which phenotypically similar diseases share pathoge-
netic mechanisms, as proposed by the syndrome family concept.3
We calculated phenotypic distances between syndromes based on
their feature vectors. This approach is described in detail in Van
Driel et al. (2006).11 In brief, we ﬁrst used the hierarchical relation-
ships between features in the relevant feature ontology to supple-802 The American Journal of Human Genetics 85, 801–808, Decembment the feature vectors with their more general ancestor features,
and subsequently calculated the phenotypic distances between all
syndrome pairs by using the cosine similarity metric, which uses
the angle between the two feature vectors as distance measure.
After calculating the phenotypic distances between syndromes,
we hierarchically clustered the phenotypes by using average
linkage. We then partitioned the resulting dendrogram into
clusters by using the ‘‘Dynamic Tree Cut’’ algorithm,28 which
creates comparable cluster sizes across different dendrograms
(data not shown). This algorithm requires a minimum cluster
size as parameter, which we arbitrarily set to ﬁve syndromes in
order to prevent the creation of large numbers of trivially small
clusters, while also avoiding the forcing of dissimilar syndromes
into oversized clusters.
Upon partitioning the syndromes into clusters, we then calcu-
lated the average biological coherence of the clusters by by using
the ‘‘Gene Ontology’’ (GO) gene function annotation29 (version
1.642) as genetic relatedness measure (the gene to GO mapping
was downloaded from the Ensembl database30 version 46 on
August 28, 2007). We considered several different measures of
gene function similarity such as shared biochemical pathways,
shared protein domains, and protein-protein interactions, and
we chose to use GO annotation because it directly reﬂects many
different kinds of functional relatedness and has the largest and
most dense coverage of genes (Table S1).
Cluster biological coherence was calculated as follows. First,
we retrieved the GO terms associatedwith the disease genes under-
lying cluster syndromes. These GO terms were then pooled across
Table 1. Overview of the Considered Syndrome Databases
OMIM
Orphaneta POSSUM HPOb MimMinerc
Num. syndromes 2070 3167 4779 5948
Num. features in ontology 864 1115 8275 1368d
Feature ontology depth:
max. (median)




13 (25) 22 (34) 7 (20) 8 (22)
Num. syndromes mapped
to disease genes
668 924 2053 2055
Num. disease genes 1038f 986 2019 1937
Reference 25 26 24 11
a Only the feature-annotated Orphanet syndromes were included in this
analysis. There were a total of 7435 syndrome IDs in the full Orphanet
database. However, Orphanet uses clinical syndrome definitions, which are
broader than the locus-based syndromes in databases such as OMIM. As
a result, multiple IDs associated with the same clinical syndrome are not
separately annotated with features.
b The Human Phenotype Ontology contains phenotype annotation for a subset
of OMIM syndromes as well as some OMIM genes. We restricted ourselves to
the 4345 syndrome records with text descriptions.
c The MimMiner text-mining conversion of the OMIM database is listed for
comparison, but was not used in this study.
d The ‘‘Anatomy’’ (A) and ‘‘Pathological Conditions, Signs, and Symptoms’’
(C23) parts of the MeSH ontology were used in the MimMiner approach.
e The number in parentheses refers to the median number of features per
syndrome after the syndrome feature vectors are expanded to include the
feature’s ontological ancestors in the feature vector.
f The Orphanet database used originally contained 569 disease genes, but this
number was expanded to 1935 via syndrome-to-gene mappings from the
OMIM database. 1038 of these were associated with feature-annotated
syndromes.er 11, 2009
all genes causing the same syndrome, resulting in a set of GO terms
annotated to the syndrome. To incorporate ontological relation-
ships between GO terms into the comparison, we added all term
ancestors to theGO term set, excluding the root terms for the three
GO categories. This approach has been shown to work as well as
more complicated approaches.31 For each syndrome pair, we deter-










where Sp(i,j) is the pairwise GO term overlap score for diseases i and
j, n is the number of GO terms meeting the speciﬁed criteria, and
Gi and Gj are the sets of GO terms associated with diseases i and j,
respectively. For each cluster, the mean pairwise overlap was used





where Sc is the genetic cohesiveness score for cluster c, Sp(i,j) is the
GO overlap score for diseases i and j, and n is the number of disease
pairs in the cluster. The mean biological coherence score across all






where S is the overall genetic cohesiveness score for the phenotype
data set, Sc is the genetic cohesiveness score for cluster c, and n is
the number of clusters in the phenotype data set.
Randomizations
We did not compare the cluster biological coherence scores
between data sets directly because the many differences between
the databases would make it hard to determine which aspects of
the database did cause the variation in the biological coherence
score. Instead, we compared the scores of the actual data sets to
those of randomly permuted data sets. Randomization was done
by reshufﬂing the features over the diseases, while maintaining
the phenotypic structure of the data sets. Thus, feature frequencies
in the data sets and feature distributions across diseases weremain-
tained, and only the feature assignment to diseases was random-
ized. In this randomization approach, disease to gene mappings
are maintained, correcting for biases resulting from the sharing
of genes between diseases, variation in number of genes per
disease, and function annotation bias of genes, because these
remain identical across both actual and randomized data sets. As
ﬁnal biological coherence measure, we used the ratios of the
cluster biological coherence scores of the actual data sets to those
of 30 randomized variants. These ratios were used as performance
metric for evaluating effect of weighting schemes or other data-
base properties. All ratio comparisons were done with the
nonparametric two-sidedWilcoxon rank sum test with continuity
correction as implemented in the R statistical software package.
HPO Supplementation Analyses
The OMIM disease phenotype annotation used by the HPO was
supplemented with feature annotation from the POSSUM data-
base. We excluded the more detailed skeletal features—those
with feature IDs above 746—which were added later to the
POSSUM database in order to better describe the skeletal abnor-
malities that this database is oriented toward. This supplementa-
tion resulted in the increase in median number of features perThe Americandisease from 14 to 38 for those diseases that could be supple-
mented. We performed the comparisons between the original
and the supplemented HPO data sets by using only the 1950
syndromes that could be supplemented with at least one POSSUM
feature. The supplemented feature vectors were further processed
analogously to the original feature vectors.
HPO Feature Ontology Truncation Procedure
The HPO feature ontology contains more than 8000 features orga-
nized into a deep hierarchical structure with a median feature
depth of 6 and a maximum depth of 13. We mapped all features
located at a depth level of ﬁve or higher (i.e., four or more steps
from the root of the HPO ontology) to their more general ancestor
features at the fourth level, resulting in a set of 1833 more broadly
deﬁned features. Where a deep feature had multiple ancestors at
this level, it was mapped to all of them. Syndrome feature vectors
were modiﬁed with this feature mapping, with deeper features
being replaced with their appropriate fourth-level ancestor
features. All features were registered only once per feature vector,
regardless of howmany deeper features they replaced. Thesemodi-
ﬁed feature vectors were further processed analogously to the full
ontology-based feature vectors.
Orphanet Feature Occurrence Frequency Weighting
Scheme
Orphanet features are annotated with occurrence frequency
estimates. These frequency estimates are divided into three classes:
Very Frequent, Frequent, and Occasional. To investigate the effect
of incorporating feature frequency estimates on syndrome clus-
tering, we weighted these three frequency classes with the weights
1.0, 0.1, and 0.01, respectively. We contrasted this scheme with
one in which the assignment order was reversed, assigning
a weight of 1.0 to the Occasional frequency class and 0.01 to the
Very Frequent class. These weighted feature vectors were further
processed analogously to the unweighted feature vectors.
Inverse Document Frequency Weighting Scheme
Features in feature vectors were weighted via the inverse docu-
ment frequency algorithm (Equation 4), which assigns higher






where Fidf is the IDF-weighted feature score, n is the total number
of phenotypes, nf is the number of phenotypes with the feature,
and F is the original feature score. In this scheme, weights increase
logarithmically with rarity. All weights were subsequently rescaled
to the 0–1 range. These weighted feature vectors were further pro-
cessed analogously to the unweighted feature vectors.
Statistical Analysis
Biological coherence scores were compared between data sets via
theWilcoxon signed rank test with continuity correction as imple-
mented in the R statistical software package. This test does not
assume normally distributed data.
Results
Incomplete Phenotype Descriptions Impair Phenome
Coherence
The median number of phenotype features per disease in
the OMIM-based HPO phenotype annotation (7) is muchJournal of Human Genetics 85, 801–808, December 11, 2009 803
Figure 1. Comprehensively Annotated Syndromes Cluster Better than Sparsely Annotated Syndromes
(A) The Ehlers-Danlos and Charcot-Marie-Tooth syndrome families overlap in the phenome landscape of the OMIM data set, but
separate when the phenotype descriptions are supplemented with POSSUM annotation. The phenome landscapes were created with
multidimensional scaling of the HPO feature-based OMIM distance matrices (left), supplemented with POSSUM annotation (right).
Themore similar the annotations of two syndromes are, the closer they are on the landscape. The background colors indicate the density
of syndromes in that region of the landscape. Lighter colors represent higher densities.
(B) Mean phenotypic similarity is consistently greater for the POSSUM-supplemented OMIM data set (red dashed lines) than for the
original OMIM data set (blue dashed lines). Besides Ehlers-Danlos (n ¼ 12) and Charcot-Marie-Tooth (n ¼ 12), the more phenotypically
diverse family of ciliopathies is also shown (n ¼ 59; Table S2). Continuous lines show the distributions of mean distances for randomly
composed syndrome families of equivalent size (n ¼ 107) for the original and supplemented OMIM data sets.less than it is for the POSSUM and Orphanet databases (22
and 13, respectively) (Table 1).We reasoned that increasing
phenotype annotation in the HPOmight aid the discovery
of biological relationships between diseases in that data-
base. We investigated this by supplementing the OMIM
disease annotation with features from the POSSUM data-
base, thus increasing the HPO disease annotation almost
3-fold from 14 features per disease to 38 features per
disease. We then hierarchically clustered all HPO pheno-
types based on their feature similarities, creating a disease
network that we could link to the biological function of
disease genes. The biological coherence of resulting HPO
phenotypic clusters was measured by the degree to which
disease genes shared GO function annotation. In brief,
GO terms were pooled across genes per disease, and the
mean degree of GO annotation overlap between all disease
pairs in a cluster was used as the cluster biological coher-804 The American Journal of Human Genetics 85, 801–808, Decembence score. The mean score over all clusters was used as
the ﬁnal biological coherence score for the data set (see
Material and Methods for more detailed description of
procedure).
Enriching the OMIM annotation in the HPO with
POSSUM annotation does indeed lead to improved pheno-
typic clustering of known syndrome families (Figure 1).
The 12 annotated subtypes of Ehlers-Danlos syndrome
and of Charcot-Marie-Tooth disease segregate better
(Figure 1A) and the detection of similarity between the
phenotypically more diverse ciliopathies is also increased
(Figure 1B). With enriched phenotype descriptions, the
HPO disease similarity matrix reﬂects underlying genetic
relationships to a much greater degree (Figure 2A; p <
1016, two-sided Wilcoxon signed rank test). We conclude
that the OMIM database from which the HPO phenotype
annotation was taken is currently greatly underannotateder 11, 2009
Figure 2. Biological Coherence of Phenotypic Clusters for Different Data Sets and Conditions
The box plots show relative enrichment of shared GO terms for genes associated with diseases within clusters compared to randomly
permutated phenotype data sets (n ¼ 30). Box limits show the 25th and 75th percentiles, whiskers extend out up to 1.53 the box range,
and points outside this range are plotted individually.
(A) The full HPO ontology results in biologically more coherent phenotype clusters than a simpliﬁed HPO ontology containing only
more general features, but only when the OMIM phenotypes are supplemented with POSSUM annotation (purple boxes).
(B) Artiﬁcial underannotation of the POSSUMandOrphanet databases by randomly halving the syndrome feature lists (‘‘sparse’’) leads to
strong reductions in cluster biological coherence. However, limiting the Orphanet syndrome descriptions to just the very frequent
features has limited impact on cluster coherence, despite the strong reduction in the average number of features per syndrome to
just 57% of the original.
(C) Weighting Orphanet features according to their prevalence within affected patients improves the biological coherence of clustered
phenotypes. Counter-weighting them by assigning higher weights to less frequently occurring features abolishes the biological
coherence of the resulting phenotype clusters almost completely.
(D)Weighting annotated features according to their speciﬁcity (number of syndromes they occur in) via the inverse document frequency
(I.D.F.) weighting scheme diminishes cluster biological coherence for well-annotated POSSUM syndromes, but improves it for
underannotated syndromes.and that this affects its performance on detecting bio-
logical relationships between disease phenotypes.
We further demonstrated this point by artiﬁcially under-
annotating the well-annotated POSSUM and Orphanet
syndromes, through the random elimination of half the
annotated features per syndrome. As expected, the perfor-
mance of POSSUM and Orphanet is much reduced when
half of the annotated features are randomly removed
(Figure 2B; p < 1016 in both cases, two-sided WilcoxonThe Americansigned rank test). These results underline the importance
of complete phenotype descriptions for phenotype-based
disease analysis and highlight the limitations of using
the OMIM database for such analyses.
Detailed Feature Ontologies Improve Phenome
Coherence
We then asked whether one would require a highly
detailed feature ontology as recently developed in HPOJournal of Human Genetics 85, 801–808, December 11, 2009 805
in order to accurately reﬂect the biology that underlies
inherited diseases. Such feature ontologies organize disease
features into a hierarchical structure, with deeper features
becoming progressively more speciﬁc. The HPO has
a comprehensive feature ontology containing more than
8000 features, in contrast to the POSSUM and Orphanet
ontologies that both contain about a thousand features
each (Table 1). It also has the deepest ontology, with a
median feature depth of 6 (as opposed to 2 for the POSSUM
and Orphanet ontologies) and a maximum depth of 13 (as
opposed to 2 and 4 for POSSUM and Orphanet, respec-
tively).
To investigate the beneﬁts of such a highly detailed
ontology, we ﬁrst hierarchically clustered all HPO pheno-
types based on their feature similarities. This created a
disease network that we could link to the biological func-
tion of disease genes. We then repeated the analysis by
using a simpliﬁed version of HPO truncating the feature
tree at three steps from the root of the ontology. This
procedure reduced the HPO feature set from a total of
8275 to just 1833 features.
Surprisingly, an initial comparison indicated that the
highly detailed feature ontology of HPO did not improve
the degree to which phenotype clustering reﬂects biolog-
ical relationships between disease genes (Figure 2A). In
fact, the use of more detailed feature deﬁnitions had a
slightly detrimental effect (p < 104, two-sided Wilcoxon
signed rank test). However, this is likely an artifact of the
previously noted underannotation of diseases in OMIM.
To conﬁrm this, we repeated the experiment with the
HPO disease annotation that had been supplemented
with features from the POSSUM database (Figure 2A). As
could be expected, the detailed phenotype ontology did
indeed improve phenome representation. The full HPO
feature ontology performed better on biological coherence
of phenotype clusters relative to the simpliﬁed ontology
(p < 1014, two-sided Wilcoxon signed rank test). This
result highlights two effects: ﬁrst, detailed and comprehen-
sive feature ontologies such as HPO enable improved
phenotype description; and second, underannotation of
disease phenotypes severely limits the beneﬁts of such
detailed feature ontologies.
Using Feature Occurrence Frequency Can Improve
Phenome Coherence
We then asked whether all phenotypic features are of equal
importance to the overall disease phenotype. We ﬁrst
restricted the phenotype descriptions to those features
that occur very frequently in the respective diseases. Even
though this leads to a considerable reduction of features
per syndrome (median 57% of original features), the bio-
logical coherence scores remained high (Figure 2B). This
result shows that the core phenotypic features that occur
most commonly in a disease best reﬂect the underlying
biological relationships.
Consistent with this, we found that if we emphasized
commonly occurring features and assigned lower weights806 The American Journal of Human Genetics 85, 801–808, Decembto infrequent features, a more biologically relevant pheno-
type clustering was obtained (Figure 2C; p < 108, two-
sidedWilcoxon signed rank test). By contrast, emphasizing
infrequent features by assigning them higher weights
almost completely abolished any recognizable biological
coherence of phenotype clusters (Figure 2C; p < 1016,
two-sided Wilcoxon signed rank test). Thus, whereas the
weighting of phenotypic features based on their frequency
of occurrence improves disease classiﬁcation, emphasizing
features that are not part of the core phenotype may have
a severe detrimental effect. This result clearly argues for the
systematic curation of phenotype data. More speciﬁcally,
the inclusion of feature frequencies appears to be a require-
ment for optimal phenotype representation, a feature that
is currently available only in Orphanet.
Emphasizing Rare Features Is Detrimental
to Phenome Coherence
It has previously been suggested that those features that
occur in many diseases will be too general to discriminate
between diseases, and too common to aid in specifying the
pattern of features that deﬁnes a disease family. Rarer
features might be more informative for the underlying
biology.8,11 We investigated this assumption for the
systematically annotated POSSUM database. In contrast
to previous studies,8,11 we ﬁnd that a weighting scheme
that uses the standard ‘‘inverse document frequency’’ (or
IDF) score is detrimental to the biological coherence
of similar phenotypes (Figure 2D; p < 107, two-sided
Wilcoxon signed rank test). Interestingly, this holds only
for fully annotated syndromes because underannotated
syndromes do beneﬁt from emphasizing rarer features
(Figure 2D; p < 1012, two-sided Wilcoxon signed rank
test). This explains previous results, which were based on
text mining of less well-annotated phenotypes. We
conclude that overall phenotypic similarity is generally
more indicative of underlying genetic relationships than
the sharing of speciﬁc features that are observed in a few
syndromes or diseases only.
Discussion
Here, we have used a biological coherence score based on
the sharing of GO annotation between diseases. We use
this scoring system to identify database characteristics
that enable a better clustering of related disease pheno-
types. GO annotation is currently themost comprehensive
description of protein function. Nevertheless, other more
speciﬁc measures of the similarity between gene products
exist, such as shared biochemical pathways,32 shared
protein domains,33 and protein-protein interactions.
These support the general trends we observe based on
the GO annotation, although smaller effects are less visible
(Table S1 and Figures S1, S2, and S3).
Our analysis of the OMIM-based HPO, POSSUM, and Or-
phanet structured disease phenotype databases highlightser 11, 2009
three areas where improvements of phenotype annotation
are required. First, the disease phenotypes in the fre-
quently used OMIM database are underannotated, and
this severely impairs the degree to which its phenotypes
reﬂect underlying disease pathology. There is therefore
a strong need to increase the phenotype annotation in
OMIM, for instance by transferring annotation from other
more comprehensive sources such as the POSSUM data-
base. Although this can be done manually, the use of
feature ontologies can greatly facilitate this process by
enabling the automated transfer of annotation between
databases. The HPO provides such a feature ontology for
the OMIM database, which makes it easy to transfer anno-
tation from another structured phenotype database. With
it we have shown that the number of features per disease
in OMIM can easily be increased, and this should much
improve its applicability for phenome-scale analyses. Our
second major ﬁnding is that a simple score of the
frequency of feature occurrence per disease, as is imple-
mented in Orphanet, reﬁnes the phenotype description
and improves database performance. Third, the use of
detailed and comprehensive feature ontologies such as
the HPO can further improve phenotype descriptions,
but only if the phenotypes are not underannotated. In
addition to these database-related ﬁndings, our analysis
also highlights a potential pitfall for phenome-scale anal-
yses as emphasizing phenotype features that are rare in
the databases does not allow one to cluster diseases more
efﬁciently. These ﬁndings have implications for future
and perhaps current database design.
Clearly, current human phenotype databases were
intended as repositories, as tools for accurate clinical diag-
nosis of syndromes, and to provide references to a selection
of the pertinent literature for speciﬁc genetic diseases and
syndromes. One could therefore argue that our plea for
improvement is demanding something that lies outside
the original scope for which these databases were designed.
In contrast, we would argue that our ability to compare and
group genes based on their sequence and function has
proven to be of immense use for genome scientists. We
thereforebelieve that thehumanphenomedeserves a repre-
sentation that allows scientists to be similarly inquisitive
and creative in distilling biologically relevant patterns.
Further down the line, we need to improve the collec-
tion of phenotype data as well as their storage. Although
curators can standardize phenotype recording in data-
bases, such efforts could be greatly assisted by the stan-
dardization of phenotype recording in the clinic.15,16
Such standardized reporting would require controlled
feature vocabularies, of which there are several in exis-
tence24–27 or under development.34 Given the difﬁculties
of designing feature vocabularies and their importance in
phenotype analysis, it might be beneﬁcial to unify termi-
nology across vocabularies. Ultimately, a complete human
phenome description incorporating all human phenotypic
variation14—including molecular phenotypes35—would
be most desirable for correlating phenotype variation toThe Americangenetic variation. Such analyses could even be performed
at the level of individual genomes and phenotypes once
sufﬁcient data from initiatives such as the Personal
Genome Project become available.22 We believe that the
time is ripe for the allocation of substantial resources to
improve human phenome annotation on the one hand
and to foster the more systematic storage of such data in
human phenotype databases on the other.
Supplemental Data
Supplemental Data include three ﬁgures and three tables and can
be found with this article online at http://www.cell.com/AJHG.
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Web Resources
The URLs for data presented herein are as follows:
Ensembl database, http://www.ensembl.org/
HPO main website, http://www.human-phenotype-ontology.org/
HPOdownload,http://bioportal.bioontology.org/ontologies/40381
GO main website, http://www.geneontology.org/
GOdownload,http://bioportal.bioontology.org/ontologies/40634




R statistical software package, http://www.r-project.org/
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